Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Injectable

Therapeutic area intelligence for Injectable with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
7
Catalysts
0
Companies
3

Companies

Anthea Pharma →
Hikma →
Lupin →

Assets

American →
Apotex →
B →
Baxter →
Extrovis →
FDA →
Propofol →

Recent signals(7)

RegulatoryAugust 17, 2026

FDA Accepts ANDA for Multiple Vitamins Injection by Apotex

The FDA has accepted Apotex's ANDA210672 for Multiple Vitamins Injection for adults, with a standard review priority.

RegulatoryAugust 11, 2026

FDA Approval Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride by Lupin

Lupin has submitted an Abbreviated New Drug Application (ANDA 216095) for a combination product containing Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride, currently under standard review by the FDA.

RegulatoryJuly 28, 2026

American Regent Issues Nationwide Recall of Papaverine Hydrochloride Injection Due to Contamination

American Regent, Inc. is recalling one lot of Papaverine Hydrochloride Injection due to contamination with glass particles.

RegulatoryJuly 21, 2026

FDA Grants Approval for Lupin's Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride

The FDA has approved ANDA216095 for a combination product containing sodium sulfate, magnesium sulfate, and potassium chloride.

StrategyJuly 18, 2026

FDA Grants Approval for Propofol ANDA220857 by Anthea Pharma

The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 220857 for Propofol submitted by Anthea Pharma.

RegulatoryJuly 17, 2026

B. Braun Medical Recalls Spinal Anesthesia Kits Due to Bupivacaine Hydrochloride Issues

Braun Medical is recalling convenience kits that contain Bupivacaine Hydrochloride in Dextrose Injection due to safety concerns.

StrategyJuly 5, 2026

FDA Grants Approval for Sodium Acetate ANDA220274 by Extrovis

The FDA has granted approval for ANDA220274, a sodium acetate product submitted by Extrovis.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.